Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolate

Antimicrob Agents Chemother. 2000 Feb;44(2):453-5. doi: 10.1128/AAC.44.2.453-455.2000.

Abstract

TEM-56 produced by a Klebsiella pneumoniae clinical isolate is a novel beta-lactamase of isoelectric point 6.4 that confers a moderate resistance level to expanded-spectrum cephalosporins. The amino acid sequence deduced from the corresponding bla gene showed two amino acid replacements with respect to the TEM-2 sequence: Glu-104 to Lys and His-153 to Arg. This enzyme showed catalytic properties close to those of TEM-18. Thus, TEM-56 appears as a new TEM mutant, an intermediary between TEM-18 and the extended-spectrum beta-lactamase TEM-21.

MeSH terms

  • Amino Acid Substitution
  • Humans
  • Inhibitory Concentration 50
  • Kinetics
  • Klebsiella pneumoniae / enzymology*
  • Klebsiella pneumoniae / genetics
  • Microbial Sensitivity Tests
  • beta-Lactamases / metabolism*

Substances

  • TEM-56 beta-lactamase
  • beta-Lactamases